Showing 21 to 40 of 80 bills
| Bill Title | Introduced | Latest Action |
|---|---|---|
|
HB 4036
(Arizona - 57th Legislature - Second Regular Session)
bulk drug substances; prohibitions |
Feb 09 2026 |
Failed
Feb 18 2026 |
|
HB 2456
(Hawaii - 2026 Regular Session)
Relating To Drugs For Weight Loss. |
Jan 27 2026 |
Reported From Hsh/Hlt (Stand. Com. Rep. No. 382-26) As Amended In Hd 1, Recommending Passage On Second Reading And Referral To Fin.
Feb 18 2026 |
|
HB 1136
(Mississippi - 2026 Regular Session)
Obesity medicine; define as within practice of medicine and allow physicians to prescribe obesity drugs via telemedicine. |
Jan 19 2026 |
Died On Calendar
Feb 12 2026 |
|
SB 2554
(Mississippi - 2026 Regular Session)
Practice of medicine; provide for use of HIPAA-compliant telecommunications systems and practice of obesity medicine. |
Jan 19 2026 |
Died In Committee
Feb 03 2026 |
|
SB 3195
(Hawaii - 2026 Regular Session)
Relating To Drugs For Weight Loss. |
Jan 28 2026 |
Referred To Hhs, Wam.
Feb 02 2026 |
|
AB 575
(California - 2025-2026 Regular Session)
Obesity Prevention Treatment Parity Act. |
Feb 12 2025 |
From Committee: Filed With The Chief Clerk Pursuant To Joint Rule 56.
Feb 02 2026 |
|
S 845
(Massachusetts - 194th Legislature (2025-2026))
An Act to protect 340B providers in the Medicaid program |
Feb 27 2025 |
Accompanied A Study Order, See S2931
Jan 29 2026 |
|
A 3369
(New Jersey - 2026-2027 Regular Session)
Requires SHBP, SEHBP, Medicaid, and NJ FamilyCare to cover anti-obesity medications. |
Jan 13 2026 |
Introduced, Referred To Assembly Health Committee
Jan 13 2026 |
|
A 1831
(New Jersey - 2026-2027 Regular Session)
Makes various changes to SHBP plan offerings and governance. |
Jan 13 2026 |
Introduced, Referred To Assembly State And Local Government Committee
Jan 13 2026 |
|
A 943
(New Jersey - 2026-2027 Regular Session)
Requires health insurance coverage of prescribed anti-obesity medication. |
Jan 13 2026 |
Introduced, Referred To Assembly Health Committee
Jan 13 2026 |
|
A 2715
(New York - 2025 Regular Session)
Requires comprehensive Medicaid coverage for the treatment of obesity |
Jan 22 2025 |
Referred To Health
Jan 07 2026 |
|
A 9360
(New York - 2025 Regular Session)
Relates to requiring Medicaid coverage of FDA-approved GLP-1 receptor agonist medications for certain purposes |
Dec 19 2025 |
Referred To Health
Jan 07 2026 |
|
A 4211
(New York - 2025 Regular Session)
Requires comprehensive coverage for treatment of obesity |
Jan 31 2025 |
Referred To Insurance
Jan 07 2026 |
|
S 3104
(New York - 2025 Regular Session)
Requires comprehensive coverage for treatment of obesity |
Jan 23 2025 |
Referred To Health
Jan 07 2026 |
|
HB 388
(Ohio - 136th Legislature (2025-2026))
Regards state employee reimbursement for GLP-1 drug costs |
Jul 01 2025 |
Referred To Committee
Sep 15 2025 |
|
SF 552
(Iowa - 2025-2026 Regular Session)
A bill for an act relating to a review of anti-obesity medications by the department of health and human services and the department of administrative services for purposes of the medical assistance program and health insurance plans for state employees. |
Mar 06 2025 |
Referred To Health And Human Services.
Jun 16 2025 |
|
SB 193
(New Mexico - 2025 Regular Session)
Weight Loss Drugs Insurance Coverage |
Jan 29 2025 |
Action Postponed Indefinitely
Jun 03 2025 |
|
SB 477
(New Mexico - 2025 Regular Session)
No Prior Authorization For Certain Drugs |
Feb 20 2025 |
Action Postponed Indefinitely
Jun 03 2025 |
|
HB 783
(Montana - 2025 Regular Session)
Generally revise health insurance laws relating to certain conditions |
Dec 14 2024 |
(H) Died In Process
May 20 2025 |
|
HB 6254
(Rhode Island - 2025 Regular Session)
An Act Relating To Human Services -- Medical Assistance |
Apr 23 2025 |
05/20/2025 Committee Recommended Measure Be Held For Further Study
May 20 2025 |
Showing 21 to 40 of 80 bills
